71 related articles for article (PubMed ID: 20924169)
41. Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster.
de Deckere EA; van Amelsvoort JM; McNeill GP; Jones P
Br J Nutr; 1999 Oct; 82(4):309-17. PubMed ID: 10655980
[TBL] [Abstract][Full Text] [Related]
42. Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver.
Rasooly R; Kelley DS; Greg J; Mackey BE
Br J Nutr; 2007 Jan; 97(1):58-66. PubMed ID: 17217560
[TBL] [Abstract][Full Text] [Related]
43. Corn oil supplementation to steers grazing endophyte-free tall fescue. II. Effects on longissimus muscle and subcutaneous adipose fatty acid composition and stearoyl-CoA desaturase activity and expression.
Pavan E; Duckett SK
J Anim Sci; 2007 Jul; 85(7):1731-40. PubMed ID: 17431049
[TBL] [Abstract][Full Text] [Related]
44. Effect of feeding rumen-protected conjugated linoleic acid on carcass characteristics and fatty acid composition of sheep tissues.
Wynn RJ; Daniel ZC; Flux CL; Craigon J; Salter AM; Buttery PJ
J Anim Sci; 2006 Dec; 84(12):3440-50. PubMed ID: 17093239
[TBL] [Abstract][Full Text] [Related]
45. Trans-10,cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible link to tissue-specific alterations of fatty acid desaturation.
Jaudszus A; Moeckel P; Hamelmann E; Jahreis G
Ann Nutr Metab; 2010; 57(2):103-11. PubMed ID: 20924169
[TBL] [Abstract][Full Text] [Related]
46. Human health effects of conjugated linoleic acid from milk and supplements.
McCrorie TA; Keaveney EM; Wallace JM; Binns N; Livingstone MB
Nutr Res Rev; 2011 Dec; 24(2):206-27. PubMed ID: 22296934
[TBL] [Abstract][Full Text] [Related]
47. Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile.
Baddini Feitoza A; Fernandes Pereira A; Ferreira da Costa N; Gonçalves Ribeiro B
Nutr Hosp; 2009; 24(4):422-8. PubMed ID: 19721921
[TBL] [Abstract][Full Text] [Related]
48. Dietary conjugated linoleic acid and body composition.
Wang Y; Jones PJ
Am J Clin Nutr; 2004 Jun; 79(6 Suppl):1153S-1158S. PubMed ID: 15159250
[TBL] [Abstract][Full Text] [Related]
49. Biological effects of conjugated linoleic acids supplementation.
Oleszczuk J; Oleszczuk L; Siwicki AK; Skopińska-Skopińska E
Pol J Vet Sci; 2012; 15(2):403-8. PubMed ID: 22844724
[TBL] [Abstract][Full Text] [Related]
50. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks.
Kelley DS; Erickson KL
Lipids; 2003 Apr; 38(4):377-86. PubMed ID: 12848282
[TBL] [Abstract][Full Text] [Related]
51. A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism.
Lehnen TE; da Silva MR; Camacho A; Marcadenti A; Lehnen AM
J Int Soc Sports Nutr; 2015; 12():36. PubMed ID: 26388708
[TBL] [Abstract][Full Text] [Related]
52. Effects of conjugated linoleic acid (CLA) on immune responses, body composition and stearoyl-CoA desaturase.
Ntambi JM; Choi Y; Park Y; Peters JM; Pariza MW
Can J Appl Physiol; 2002 Dec; 27(6):617-28. PubMed ID: 12501000
[TBL] [Abstract][Full Text] [Related]
53. Adipocyte response to conjugated linoleic acid.
Yamasaki M; Yanagita T
Obes Res Clin Pract; 2013; 7(4):e235-42. PubMed ID: 24455759
[TBL] [Abstract][Full Text] [Related]
54. Changes in body composition with conjugated linoleic acid.
DeLany JP; West DB
J Am Coll Nutr; 2000 Aug; 19(4):487S-493S. PubMed ID: 10963469
[TBL] [Abstract][Full Text] [Related]
55. [Conjugated linoleic acid (CLA) and its relationship with cardiovascular disease and associated risk factors].
Funck LG; Barrera-Arellano D; Block JM
Arch Latinoam Nutr; 2006 Jun; 56(2):123-34. PubMed ID: 17024956
[TBL] [Abstract][Full Text] [Related]
56. Nutrient Regulation: Conjugated Linoleic Acid's Inflammatory and Browning Properties in Adipose Tissue.
Shen W; McIntosh MK
Annu Rev Nutr; 2016 Jul; 36():183-210. PubMed ID: 27431366
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies.
Larsen TM; Toubro S; Astrup A
J Lipid Res; 2003 Dec; 44(12):2234-41. PubMed ID: 12923219
[TBL] [Abstract][Full Text] [Related]
58. The body fat-lowering effect of conjugated linoleic acid: a comparison between animal and human studies.
Navarro V; Fernández-Quintela A; Churruca I; Portillo MP
J Physiol Biochem; 2006 Jun; 62(2):137-47. PubMed ID: 17217167
[TBL] [Abstract][Full Text] [Related]
59. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies.
Gaullier JM; Berven G; Blankson H; Gudmundsen O
Lipids; 2002 Nov; 37(11):1019-25. PubMed ID: 12558050
[TBL] [Abstract][Full Text] [Related]
60. Systemic effects of white adipose tissue dysregulation and obesity-related inflammation.
Guri AJ; Bassaganya-Riera J
Obesity (Silver Spring); 2011 Apr; 19(4):689-700. PubMed ID: 20930712
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
